Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011
Could pulmonary tuberculosis present without any inflammatory response? Source: Eur Respir J 2005; 26: Suppl. 49, 420s Year: 2005
Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009
Relationship between the whole blood interferon-gamma responses and the risk of active tuberculosis Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection Year: 2006
Role of adaptive immunity in clinical variability of active tuberculosis patients Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases Year: 2021
Collapso-surgical treatment of patients with diffused destructive tuberculosis of the lungs Source: Eur Respir J 2002; 20: Suppl. 38, 343s Year: 2002
Understanding the immune response to tuberculosis in children versus adults Source: International Congress 2014 – PG20 Global evaluation of tuberculosis from children to adults Year: 2014
IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT) Source: Eur Respir J 2001; 18: Suppl. 33, 307s Year: 2001
Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007
An influence of small doses of corticosteroids on immune defense in active pulmonary tuberculosis in humans Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009
The status of populations of cell-mediated lung immunity effectors after chemotherapy of experimental MDR tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 656s Year: 2005
Eosinophilia and predominant Th2 immune responses are rarely evident in disseminated tuberculosis Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers Year: 2016
Different antimycobacterial activity of macrophages in various lung tuberculosis legions of patients Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020
Differences between local and systemic inflammatory response in patients with community acquired pneumonia (CAP) Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011
In vitro immune response to Mycobacterium tuberculosis antigensSource: Eur Respir J 2005; 26: Suppl. 49, 22s Year: 2005
An audit of local non tuberculosis mycobacterial cultures Source: Eur Respir J 2004; 24: Suppl. 48, 189s Year: 2004
Tuberculosis infection treatment: Their effect on the immune response in children Source: Annual Congress 2010 - Tuberculosis in children Year: 2010
Cellular and humoral immune response in non HIV infected tuberculous patients in Upper Egypt Source: International Congress 2015 – Science and biomarkers in TB Year: 2015
Utility of Th1-cell immune responses in differentiating active tuberculosis from latent tuberculosis infection Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014